Gallacher Capital Management LLC Catalyst Pharmaceuticals, Inc. Transaction History
Gallacher Capital Management LLC
- $205 Billion
- Q1 2025
A detailed history of Gallacher Capital Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Gallacher Capital Management LLC holds 16,223 shares of CPRX stock, worth $358,041. This represents 0.19% of its overall portfolio holdings.
Number of Shares
16,223Holding current value
$358,041% of portfolio
0.19%Shares
4 transactions
Others Institutions Holding CPRX
# of Institutions
390Shares Held
99.9MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$413 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$187 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$122 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$75.5 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$69.2 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.27B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...